Kulthanan Kanokvalai, Jiamton Sukhum, Taiyaitiang Chanya, Pinkaew Sumruay, Suthipinittharm Puan
Department of Dermatology, Siriraj Hospital, Mahidol University, 2 Prannok Rd, Bangkoknoi, Bangkok 10700, Thailand.
J Med Assoc Thai. 2006 Oct;89(10):1670-6.
Previous reports of direct immunofluorescence (DIF) studies of the skin biopsies in scleroderma were either negative or positive at various percentages and patterns. The present study was designed to evaluate the positive yield and pattern of DIF in Thai patients with scleroderma and its possible clinical correlation.
Twenty-two patients with localized or systemic sclerosis, who attended the Department of Dermatology, Siriraj Hospital, from 1996 to 2002, were enrolled in the present study. Skin biopsy was performed for DIF studies.
Nine out of 22 patients were diagnosed with systemic sclerosis (SS), eleven with morphea, and two with overlapping syndrome. Fifteen of 22 patients (68%) had positive DIF findings; seven of nine (78%) patients with SS, six of eleven (55%) patients with morphea and two of two (100%) with overlapping syndrome. The common sites of deposit in SS, morphea and overlapping syndrome were dermo-epidermal junction and epidermal nuclei. The common immunoreactant deposit in all groups was IgM. There was no significant difference in the comparison of DIF findings with duration of biopsy lesion, clinical correlation, and the positive result of serum antinuclear antibody (ANA) in the three groups of patients.
Positive DIF yield in the present study was higher than previous reports from Western countries. Similar to the study reported from Western country, there was no statistical significant difference in comparison of DIF findings with the duration of lesion, clinical correlation, and the positive result ofserum ANA in our three groups of patients. However; patients with SS had a tendency to give more frequently positive ENS and DEJ deposits than those with morphea.
先前关于硬皮病皮肤活检直接免疫荧光(DIF)研究的报告结果各异,呈阴性或阳性,比例和模式各不相同。本研究旨在评估泰国硬皮病患者DIF的阳性率、模式及其可能的临床相关性。
选取1996年至2002年在诗里拉吉医院皮肤科就诊的22例局限性或系统性硬化症患者纳入本研究。进行皮肤活检以进行DIF研究。
22例患者中,9例被诊断为系统性硬化症(SS),11例为硬斑病,2例为重叠综合征。22例患者中有15例(68%)DIF结果呈阳性;9例SS患者中有7例(78%),11例硬斑病患者中有6例(55%),2例重叠综合征患者中有2例(100%)。SS、硬斑病和重叠综合征中沉积物的常见部位是真皮表皮交界处和表皮细胞核。所有组中常见的免疫反应物沉积物是IgM。三组患者在DIF结果与活检病变持续时间、临床相关性以及血清抗核抗体(ANA)阳性结果的比较中无显著差异。
本研究中DIF的阳性率高于西方国家先前的报告。与西方国家报道的研究相似,在我们的三组患者中,DIF结果与病变持续时间、临床相关性以及血清ANA阳性结果的比较无统计学显著差异。然而,SS患者的EN和DEJ沉积物阳性频率往往高于硬斑病患者。